retatrutide vs slu pp 332 SLU-PP-332 Retatrutide: New Medicines for Obesity Problems SLU-PP-332 Peptide Guide: Dosing, Reconstitution

Known GLP-1 side effects include: nausea, vomiting, diarrhea, dizziness, increased heart rate, infections, headaches, indigestion, pancreatitis, medullary thyroid cancer, sudden kidney injury, worsening diabetic-related retinopathy, shortness of breath, wheezing, hives, difficulty swallowing, rash, abdominal pain and feelings of doom or dread

doi: 10.1016/j.jconrel.2024.10.026 94 LiuQ.JianW.WangL.YangS.NiuY.XieS.et al

GLP-1 medicines are prescription drugs and should only be started after evaluation by a qualified doctor.

In cases of confirmed, severe gastroparesis attributable to GLP-1 therapy, medication discontinuation is generally recommended, consistent with FDA labeling that these agents are not recommended for patients with severe gastroparesis

Y.PasschierJ.KoesB